⌘K
t
Croda International Plc announced on 4 July 2023 that it successfully completed the acquisition of Solus Biotech. This followed receipt of unconditional approval from South Korean regulatory authorities. The initial agreement for Croda to acquire Solus Biotech was announced on 6 February 2023.
| Date | 4 Jul 2023 |
| Time | 08:02:32 |
| Category | Acquisitions and alliances |
| ID | 8899E |
Regulatory News Release
4 July 2023
Croda successfully completes acquisition of Solus Biotech
Croda International Plc ('Croda') today confirms that, following receipt of unconditional approval from the South Korean regulatory authorities, it has now successfully completed the acquisition of Solus Biotech, a global leader in premium, biotechnology-derived active ingredients for beauty care and pharmaceuticals.
This follows the announcement on 6 February 2023 that Croda had reached an agreement to acquire Solus Biotech.
-ENDS-
Further information:
Investors: David Bishop, Croda +44 7823 874428
Media: Charlie Armitstead, Teneo +44 7703 330269
About Croda:
Croda is the company that uses smart science to create high performance ingredients and technologies that improve lives. For more information see: www.croda.com.